Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Meeco-OD
- Development stage
- Unknown
- Lead developer
- Droplet Life Science
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Meeco-OD** is an oral fixed-dose combination capsule from Droplet Life Science containing methylcobalamin and alpha-lipoic acid. Methylcobalamin is the active coenzyme form of vitamin B12 and supports vitamin B12-dependent neuronal and one-carbon metabolic processes, while alpha-lipoic acid is a redox-active antioxidant and metabolic cofactor. The product is positioned for vitamin B12 deficiency and supportive management of peripheral neuropathy.
- Brand names
- Meeco-OD
- Other names
- methylcobalamin + alpha-lipoic acid
02
Targets
MTR (Methionine synthase)
Beyond the preview
Go deeper on Meeco-OD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Meeco-OD.